ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Tyrosine kinases have potential effect also in patients presenting without chronic myeloid leukemia and with rare <i>BCR-ABL1</i> fusion transcripts, and should probably be a part of the treatment approach.